Found: 9
Select item for more details and to access through your institution.
Antibody Affinity, Total Antibody Activity, and Protein Content to Anti-HBs Antigen Among Sudanese and Chinese Using Terminal Antibody Method.
- Published in:
- Clinical Laboratory, 2019, v. 65, n. 7, p. 1179, doi. 10.7754/Clin.Lab.2019.181215
- By:
- Publication type:
- Article
Functional evaluation of TMEM176B and its predictive role for severe respiratory viral infection through integrated analysis of single‐cell and bulk RNA‐sequencing.
- Published in:
- Journal of Medical Virology, 2024, v. 96, n. 10, p. 1, doi. 10.1002/jmv.29954
- By:
- Publication type:
- Article
Refractory chylous pleural effusion with systemic lupus erythematosus: Surgical treatment when steroid/immunosuppressant resistant.
- Published in:
- Zeitschrift für Rheumatologie, 2019, v. 78, n. 8, p. 797, doi. 10.1007/s00393-018-0545-z
- By:
- Publication type:
- Article
Author Correction: Real-world evidence and clinical observations of the treatment of advanced non-small cell lung cancer with PD-1/PD-L1 inhibitors.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
Curative effect assessment of immunotherapy for non‐small cell lung cancer: The "blind area" of Immune Response Evaluation Criteria in Solid Tumors (iRECIST).
- Published in:
- Thoracic Cancer, 2019, v. 10, n. 4, p. 587, doi. 10.1111/1759-7714.13010
- By:
- Publication type:
- Article
Alectinib treatment response in lung adenocarcinoma patient with novel EML4‐ALK variant.
- Published in:
- Thoracic Cancer, 2018, v. 9, n. 10, p. 1327, doi. 10.1111/1759-7714.12834
- By:
- Publication type:
- Article
Proteomic analysis and experimental validation reveal the blood–brain barrier protective of Huanshaodan in the treatment of SAMP8 mouse model of Alzheimer's disease.
- Published in:
- Chinese Medicine, 2024, v. 19, n. 1, p. 1, doi. 10.1186/s13020-024-01016-7
- By:
- Publication type:
- Article
Real-world evidenceand clinical observations of the treatment of advanced non-small cell lung cancer with PD-1/PD-L1 inhibitors.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. 1, doi. 10.1038/s41598-019-40748-7
- By:
- Publication type:
- Article
Huanshaodan regulates microglial glucose metabolism reprogramming to alleviate neuroinflammation in AD mice through mTOR/HIF-1α signaling pathway.
- Published in:
- Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1434568
- By:
- Publication type:
- Article